Discusses President Ma Ying-jeou's decision to accept the resignation of Academia Sinica President Wong Chi-huey amidst the OBI Pharma scandal, focusing on the ethical standards for academic leaders.
A critique of Academia Sinica President Wong Chi-huey and his daughter’s sale of OBI Pharma stock. The author argues that the public is missing the point: the focus should be on why the broker suggested selling exactly 10 lots (likely to evade large-shareholder reporting thresholds) and what the long-term pattern of selling reveals about Wong's lack of confidence in the company's future before the unblinding results.